Institutional Ownership Catalyst Pharmaceuticals, Inc. (CPRX)
This table provides information about the institutional ownership of Catalyst Pharmaceuticals, Inc. (CPRX). We have compiled data on the 345 institutions that hold shares in the stock, with a total of 98.4 Million shares, which have been reported (via 13F filing form) to have a value of $2.13 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Pictet Asset Management Holding Sa
Carouge, V8 |
Feb 12, 2025 Q4 2024 |
15,969
shares
|
$345,249
0.0% of portfolio
|
Q4 2024
Added 27.36%
|
|
Aj Wealth Strategies, LLC
|
Jul 20, 2023 Q2 2023 |
15,241
shares
|
$329,510
0.01% of portfolio
|
Q4 2022
Reduced 4.57%
|
|
Ieq Capital, LLC
|
Jan 31, 2025 Q4 2024 |
15,013
shares
|
$324,581
0.0% of portfolio
|
Q4 2024
New holding
|
|
Lanham O'Dell & Company, Inc.
Hurricane, WV |
Feb 06, 2025 Q4 2024 |
15,000
shares
|
$324,300
0.17% of portfolio
|
Q4 2024
Reduced 11.76%
|
|
Bank Of Montreal
Toronto, A6 |
Feb 13, 2025 Q4 2024 |
14,879
shares
|
$321,683
0.0% of portfolio
|
Q4 2024
Added 6.25%
|
|
Sherbrooke Park Advisers LLC
White Plains, NY |
Feb 14, 2025 Q4 2024 |
14,785
shares
|
$319,651
0.1% of portfolio
|
Q4 2024
Reduced 7.09%
|
|
Emc Capital Management
Houston, TX |
Jan 23, 2025 Q4 2024 |
14,761
shares
|
$319,132
0.17% of portfolio
|
Q4 2024
Added 509.71%
|
|
Spire Wealth Management
|
Jan 24, 2025 Q4 2024 |
14,429
shares
|
$311,954
0.01% of portfolio
|
Q4 2024
Added 1342.9%
|
|
Walleye Capital LLC
Plymouth, MN |
Feb 13, 2025 Q4 2024 |
14,183
shares
|
$306,636
0.0% of portfolio
|
Q4 2024
Reduced 94.29%
|
|
Navellier & Associates Inc
Reno, NV |
Feb 03, 2025 Q4 2024 |
14,163
shares
|
$306,204
0.04% of portfolio
|
Q4 2024
Added 15.2%
|
|
Jump Financial, LLC
Chicago, IL |
Feb 13, 2025 Q4 2024 |
14,074
shares
|
$304,279
0.01% of portfolio
|
Q4 2024
Reduced 59.72%
|
|
Cynosure Management, LLC
Salt Lake City, UT |
Feb 12, 2025 Q4 2024 |
14,048
shares
|
$303,717
0.05% of portfolio
|
Q4 2024
Reduced 20.79%
|
|
J. Goldman & CO LP
New York, NY |
Feb 14, 2025 Q4 2024 |
13,500
shares
|
$291,870
0.01% of portfolio
|
Q3 2024
Reduced 33.33%
|
|
Creative Planning
Overland Park, KS |
Feb 14, 2025 Q4 2024 |
13,104
shares
|
$283,308
0.0% of portfolio
|
Q4 2024
Added 2.99%
|
|
Advantage Alpha Capital Partners LP
San Francisco, CA |
Feb 11, 2025 Q4 2024 |
13,050
shares
|
$282,141
0.07% of portfolio
|
Q4 2024
Reduced 48.21%
|
|
Brevan Howard Capital Management LP
St. Helier, Y9 |
Feb 14, 2025 Q4 2024 |
12,817
shares
|
$277,103
0.0% of portfolio
|
Q4 2024
Reduced 36.14%
|
|
Eqis Capital Management, Inc.
San Rafael, CA |
Feb 13, 2025 Q4 2024 |
12,710
shares
|
$274,790
0.02% of portfolio
|
Q4 2024
Reduced 20.11%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
12,538
shares
|
$271,071
0.0% of portfolio
|
Q4 2022
New holding
|
|
Rockefeller Capital Management L.P.
New York, NY |
Feb 13, 2025 Q4 2024 |
12,516
shares
|
$270,595
0.0% of portfolio
|
Q4 2024
Added 0.36%
|
|
Westover Capital Advisors, LLC
Wilmington, DE |
Feb 06, 2025 Q4 2024 |
12,505
shares
|
$270,358
0.06% of portfolio
|
Q4 2024
Reduced 2.11%
|
|
Ashton Thomas Private Wealth, LLC
Scottsdale, AZ |
Feb 06, 2025 Q4 2024 |
12,115
shares
|
$261,926
0.01% of portfolio
|
Q4 2024
Added 2.33%
|
|
Meeder Asset Management Inc
|
Feb 12, 2025 Q4 2024 |
11,833
shares
|
$255,829
0.02% of portfolio
|
Q4 2024
Added 163.13%
|
|
Ameritas Investment Partners, Inc.
Lincoln, NE |
Feb 13, 2025 Q4 2024 |
11,696
shares
|
$252,867
0.01% of portfolio
|
Q4 2024
Added 5.22%
|
|
Tema Etfs LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
11,352
shares
|
$245,430
0.1% of portfolio
|
Q4 2024
New holding
|
|
Neos Investment Management LLC
Westport, CT |
Feb 12, 2025 Q4 2024 |
11,352
shares
|
$245,430
0.01% of portfolio
|
Q1 2024
New holding
|